ELISA Analyzers Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as increasing demand for efficient tests for diagnosing prevalence of infectious diseases and growing need for technologically advanced instruments for disease detection, etc.
Enzyme Linked Immunosorbent Assay (ELISA) is a laboratory test that is utilized for the detection of antibodies in the blood. The ELISA is based on the principle of antibody and antigen interaction, and thereby is utilized in disease diagnosis. Analyzers are automated instruments which perform distinct steps of the assays and provide accurate and reproducible outcomes.
Moreover, the growing incidences of HIV, hepatitis, cancer, etc. and rising involvement of ELISA analyzers in research and development involved in immunology and drug development are propelling the market demand for ELISA analyzers and thus supporting the market growth and expected to propel it in the forecast period.
Rising Prevalence of Infectious Diseases
in 2019,296 million people were affected with Hepatitis B infection, with approximately 1.5 million new infections developing each year.
Download Free Sample ReportGrowing Demand for Technologically Advanced Tools in Immunological field
Rising Demand for Measuring Enzyme Activity
The measurement of enzyme activity, along with the detection of soluble proteins, cytokines and other protein bodies is fueling the ELISA analyzers market demand. Additionally, the growing case of allergy has led to demand for diagnostic techniques such as ELISA. ELISA is a widely used diagnostic technique in detection of food allergies. Furthermore, the indirect IgE-ELISA method is frequently used to detect allergen-specific IgE in the serum samples, due to its simplicity and low cost compared with other automated systems. For instance, In July 2018, Dynex Technologies announced its global Partnership with ZEUS Scientific. In August 2021, Zeus Scientific Inc obtained FDA authorization to use the Dynex Agility, Dynex DSX, or Dynex DS2 Automated ELISA Systems to run the ZEUS ELISA SARS-SoV-2 total antibody test system. The surge in market demand of ELISA analyzers is experienced with the increased sales and rising demand for ELISA test kits during the COVID-19 duration and is anticipated to bolster the ELISA analyzer market in the forecast period.
Recent Developments
ELISA is utilized to quantify antibody titers which are further utilized for the assessment of immunogenicity during vaccine development. Hence, several companies leading to their vaccine development have an increased demand for ELISA analyzers. For instance, a leading pharmaceutical company, Sanofi Incorporation has 10 vaccine candidates in its pipeline according to the latest updates at the Q2 2022 results meeting, which was held in July 2022.
Market Segmentation
ELISA Analyzers Market is segmented based on the type, mode, application, end user, and region. Based on the type, the market is further segmented into optical filter ELISA analyzer and optical grating ELISA analyzers. Based on the mode, the market is segmented into automated ELISA analyzers and semi-automated analyzers. Based on application, the market is further fragmented into immunology, vaccine development, drug monitoring, and others. Depending on the End user, the market is segmented into, biotechnology companies, pharmaceutical companies, contract research organization, and diagnostic laboratories. Based on the region, the Market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Market Players
Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, Merck KGaA, F. Hoffmann-La Roche Ltd, Danaher Corporation, BioTech, Agilent Technologies, QIAGEN, and PerkinElmer Inc.., etc.., are some of the major players operating in the Global ELISA Analyzers Market.
Attribute | Details |
Base Year | 2022 |
Historical Years | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | Type Mode Application End User |
Regional Scope | North America; Asia Pacific; Europe; South America; Middle East & Africa |
Country Scope | United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa; Kuwait |
Key Companies Profiled | Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, Merck KGaA, F. Hoffmann-La Roche Ltd, Danaher Corporation, BioTech, Agilent Technologies, QIAGEN, and PerkinElmer Inc. |
Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |